These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21800467)

  • 21. A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety.
    Folb PI; Bernatowska E; Chen R; Clemens J; Dodoo AN; Ellenberg SS; Farrington CP; John TJ; Lambert PH; Macdonald NE; Miller E; Salisbury D; Schmitt HJ; Siegrist CA; Wimalaratne O
    Am J Public Health; 2004 Nov; 94(11):1926-31. PubMed ID: 15514229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meeting of the Global Advisory Committee on Vaccine Safety, December 2010.
    Wkly Epidemiol Rec; 2011 Jan; 86(5):38-43. PubMed ID: 21299033
    [No Abstract]   [Full Text] [Related]  

  • 23. Meeting of Global Advisory Committee on Vaccine Safety, 18-19 June 2008.
    Wkly Epidemiol Rec; 2008 Aug; 83(32):287-92. PubMed ID: 18689006
    [No Abstract]   [Full Text] [Related]  

  • 24. Global Advisory Committee on Vaccine Safety, 6-7 June 2006.
    Wkly Epidemiol Rec; 2006 Jul; 81(28):273-8. PubMed ID: 16841398
    [No Abstract]   [Full Text] [Related]  

  • 25. Meeting of the Strategic Advisory Group of Experts on immunization, April 2013 – conclusions and recommendations.
    Wkly Epidemiol Rec; 2013 May; 88(20):201-6. PubMed ID: 23696983
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: Communicating vaccine safety - the Vienna Vaccine Safety Initiative.
    Rath B
    Curr Drug Saf; 2015; 10(1):3-4. PubMed ID: 25859667
    [No Abstract]   [Full Text] [Related]  

  • 27. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 28. Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015.
    Giersing BK; Modjarrad K; Kaslow DC; Moorthy VS; ;
    Vaccine; 2016 Jun; 34(26):2865-2869. PubMed ID: 26993336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global Advisory Committee on Vaccine Safety, 20-21 June 2002.
    Wkly Epidemiol Rec; 2002 Nov; 77(47):389-94. PubMed ID: 12498023
    [No Abstract]   [Full Text] [Related]  

  • 30. Global Advisory Committee on Vaccine Safety, 11-12 June 2003.
    Wkly Epidemiol Rec; 2003 Aug; 78(32):282-4. PubMed ID: 15581216
    [No Abstract]   [Full Text] [Related]  

  • 31. Global Advisory Committee on Vaccine Safety, 2-3 December 2015.
    Wkly Epidemiol Rec; 2016 Jan; 91(3):21-31. PubMed ID: 26829825
    [No Abstract]   [Full Text] [Related]  

  • 32. Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 May; 33(ACS-3):1-23. PubMed ID: 17520774
    [No Abstract]   [Full Text] [Related]  

  • 33. Menactra: a meningococcal conjugate vaccine.
    Med Lett Drugs Ther; 2005 Apr; 47(1206):29-31. PubMed ID: 15821633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.
    Abdelnour A; Silas PE; Lamas MR; Aragón CF; Chiu NC; Chiu CH; Acuña TH; Castrejón Tde L; Izu A; Odrljin T; Smolenov I; Hohenboken M; Dull PM
    Vaccine; 2014 Feb; 32(8):965-72. PubMed ID: 24397906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on prevention of meningococcal disease: focus on tetravalent meningococcal conjugate vaccine.
    Mehlhorn AJ; Balcer HE; Sucher BJ
    Ann Pharmacother; 2006 Apr; 40(4):666-73. PubMed ID: 16595570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capacity for a global vaccine safety system: the perspective of national regulatory authorities.
    Graham JE; Borda-Rodriguez A; Huzair F; Zinck E
    Vaccine; 2012 Jul; 30(33):4953-9. PubMed ID: 22658930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global Advisory Committee on Vaccine Safety, 17-18 December 2008.
    Wkly Epidemiol Rec; 2009 Jan; 84(5):37-40. PubMed ID: 19180768
    [No Abstract]   [Full Text] [Related]  

  • 38. International note. Global Advisory Committee on Vaccine Safety 11-12 June 2003.
    Can Commun Dis Rep; 2004 Apr; 30(7):66-8. PubMed ID: 15109092
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccine safety. Vaccine Safety Advisory Committee.
    Wkly Epidemiol Rec; 1999 Oct; 74(41):337-40. PubMed ID: 10613107
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
    Szenborn L; Czajka H; Brzostek J; Konior R; Caubet M; Ulianov L; Leyssen M
    Pediatr Infect Dis J; 2013 Jul; 32(7):777-85. PubMed ID: 23838777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.